logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
B

Blanca González-Farré

idibaps
H指数:34
被引数:5,253

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genomic Architecture of IRF4 Rearrangements in Children and Adult Large B-cell Lymphomas

儿童和成人大型B细胞淋巴瘤中IRF4重排的基因组结构

Blood Advances
IF7.1
2026-07-200
OA
Ariadna Colmenero; Leonie Frauenfeld; Sara Mato; Julia Salmeron-Villalobos; Vicente Arredondo-Prats; Joan Enric Ramis-Zaldivar; Anna Montaner; Natalia Castrejón de Anta; Blanca Gonzalez-Farre; Noelia García; Jaime Verdú-Amorós; Mara Andrés; Maitane Andión; Daniel Azorín; Verónica Celis; María Socorro Rodriguez-Pinilla; Carlos Aliste Santos; Eric D Hsi; Gabriela Gheorghe; Rachel Mariani
Ki67 dynamic predicts endocrine sensitivity in estrogen receptor-positive/HER2-negative breast cancer patients undergoing preoperative endocrine therapy

Ki67动态变化可预测接受术前内分泌治疗的雌激素受体阳性/HER2阴性乳腺癌患者的内分泌敏感性。

ESMO Open
IF8.3
2025-10-160
OAAI
R. Gómez-Bravo; B. Walbaum; M. Bergamino; O. Martínez-Sáez; F. Schettini; E. Seguí; I. García-Fructuoso; T. Pascual; N. Chic; M. González; A. Rodríguez; M. Rey; P. Giménez-Xavier; P. Blasco; O. Castillo; P. Galván; E. Sanfeliu; B. González-Farré; M. Vidal; B. Adamo; F. Brasó-Maristany; A. Prat; M. Muñoz
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial

PD1疗法在PD1高表达mRNA肿瘤中的疗效：SOLTI-1904 ACROPOLI II期试验中队列1和队列2的结果

ESMO Open
IF8.3
2025-09-300
OAAI
E. Seguí; F. Brasó-Maristany; T. Pascual; E. Sanfeliu; I. Victoria; C. Saura; C. Hierro; A. López-González; Y. Izarzugaza; E. Ciruelos; J. Gavilá; F. Racca; J.M. Cejalvo; K. Amillano; L. Paz-Ares; M. Juan; E. Felip; E. Garralda; B. González; A. Arance; J. Martín-Liberal; B. Conte; B. Walbaum; A. Indacochea; O. Castillo; P. Blasco; F. Pardo; Á. Aguirre; V. Sirenko; X. González; P. Galván; A. Vivancos; J.M. Ferrero-Cafiero; A. Mulero-Sánchez; F. Salvador; G. Villacampa; R. Mesía; A. Cervantes; A. Prat; J. Tabernero
Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trial

帕博西利和曲妥珠单抗用于HER2阳性转移性乳腺癌：SOLTI-1303-PATRICIA试验A组和B组的最终总生存结果

ESMO Open
IF8.3
2025-09-010
OAAI
T. Pascual; G. Villacampa; M. Oliveira; S. Escrivá-de-Romaní; S. Pernas; L. Paré; B. Adamo; E. Martínez; J. Cortés; A. Perelló; M. Galan; M. Melé; L. Villanueva; M. Gonzalez-Rodriguez; P. Tolosa; B. González-Farré; P. Galván; J. Canes; P. Nuciforo; J.M. Ferrero-Cafiero; X. González-Farré; P. Villagrasa; A. Prat; E. Ciruelos
Preoperative Radiotherapy-Induced Molecular and Immune Modulation in Early-Stage Breast Cancer: Results from the YOUNGSTER Trial

术前放疗诱导的分子和免疫调控在早期乳腺癌中的作用：YOUNGSTER试验的结果

international journal of radiation oncology biology physics
IF0
2025-08-050
OA
Carles Gomà; Meritxell Mollà; Gabriela Oses; Esther Sanfeliu; Adela Rodríguez-Hernández; Blanca González-Farré; Patricia Galván; Valeria Sirenko; Oleguer Castillo; Paula Blasco; Alba Llop-Guevara; Violeta Serra; Sergi Ganau; Belén Úbeda; Xavier Bargalló; Carla Cases; Artur Latorre-Musoll; Olga Martínez-Sáez; Isabel Garcia-Fructuoso; Raquel Gómez-Bravo; Francesco Schettini; Barbara Adamo; Tomás Pascual; Maria Vidal; Montserrat Muñoz; Maria Laplana; Isaac Cebrecos; Eduard Mension; Aleix Prat; Fara Brasó-Maristany
Correlation of the HER2DX Genomic Test withPathologic Features in Early-Stage HER2+BreastCancer
LABORATORY INVESTIGATION
IF4.2
2025-03-010
PRE
Sanfeliu, Esther; Martinez-Romero, Anabel; Marin-Aguilera, Mercedes; Gonzalez-Farre, Blanca; Galvan, Patricia; Infantes, Angela Aguirre; Alarcon, Valeria Sirenko; Blasco, Paula; Castillo, Oleguer; Hernandez-Illan, Eva; Jares, Pedro; Puig-Butille, Joan Anton; Martinez, Antonio; Munoz, Montserrat; Losada, MariaVidal; Pascual, Tomas; Martinez, Olga; Solis, Elia Segui; Garcia-Fructuoso, Isabel; Cejalvo, Juan Miguel; Ciruelos, Eva; Brunet, Laia Pare; Vivancos, Ana; Villagrasa, Patricia; Buckingham, Wesley; Parker, Joel; Braso-Maristany, Fara; Prat, Aleix
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response
NATURE COMMUNICATIONS
IF15.7
2024-07-111
OAAI
Braso-Maristany, Fara; Ferrero-Cafiero, Juan Manuel; Falato, Claudette; Martinez-Saez, Olga; Cejalvo, Juan Miguel; Margeli, Mireia; Tolosa, Pablo; Salvador-Bofill, Francisco Javier; Cruz, Josefina; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Odena, Andreu; Serra, Violeta; Pardo, Francisco; Luna Barrera, Ana Maria; Arumi, Miriam; Guerra, Juan Antonio; Villacampa, Guillermo; Sanchez-Bayona, Rodrigo; Ciruelos, Eva; Espinosa-Bravo, Martin; Izarzugaza, Yann; Galvan, Patricia; Matito, Judith; Pernas, Sonia; Vidal, Maria; Santhanagopal, Anu; Sellami, Dalila; Esker, Stephen; Fan, Pang-Dian; Suto, Fumitaka; Vivancos, Ana; Pascual, Tomas; Prat, Aleix; Oliveira, Mafalda
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
SCIENTIFIC REPORTS
IF3.9
2024-07-112
OAAI
Lorman-Carbo, Natalia; Martinez-Saez, Olga; Fernandez-Martinez, Aranzazu; Galvan, Patricia; Chic, Nuria; Garcia-Fructuoso, Isabel; Rodriguez, Adela; Gomez-Bravo, Raquel; Schettini, Francesco; Blasco, Paula; Castillo, Oleguer; Gonzalez-Farre, Blanca; Adamo, Barbara; Vidal, Maria; Munoz, Montserrat; Perou, Charles M.; Malumbres, Marcos; Gavila, Joaquin; Pascual, Tomas; Prat, Aleix; Braso-Maristany, Fara
Characterizing Immune Infiltration in Metastatic Hormone Receptor-Positive/HER2Negative Breast Cancer: A Comprehensive Translational Analysis from four SOLTI Clinical Trials
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Segui, Elia; Sanfeliu, Esther; Braso-Maristany, Fara; Gonzalez-Farre, Blanca; Salvador, Fernando; Angelats, Laura; Villanueva, Lorea; Espinosa, Alejandra; Galvan, Patricia; Fernandez, Esther; Gonzalez-Farre, Xavier; Escriva-De-Romani, Santiago; Chic, Nuria; Ciruelos, Eva; Saura, Cristina; Manso, Luis; Oliveira, Mafalda; Tabernero, Josep; Prat, Aleix; Pascual, Tomas
Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy
NPJ BREAST CANCER
IF7.6
2024-03-063
OAAI
Pascual, Tomas; Fernandez-Martinez, Aranzazu; Agrawal, Yash; Pfefferle, Adam D.; Chic, Nuria; Braso-Maristany, Fara; Gonzalez-Farre, Blanca; Pare, Laia; Villacampa, Guillermo; Saura, Cristina; Hernando, Cristina; Munoz, Montserrat; Galvan, Patricia; Gonzalez-Farre, Xavier; Oliveira, Mafalda; Gil-Gil, Miguel; Ciruelos, Eva; Villagrasa, Patricia; Gavila, Joaquin; Prat, Aleix; Perou, Charles M.
Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer
ESMO OPEN
IF8.3
2024-03-018
OAAI
Marin-Aguilera, M.; Jares, P.; Sanfeliu, E.; Villacampa, G.; Hernandez-lllan, E.; Martinez-Puchol, A. I.; Shankar, S.; Gonzalez-Farre, B.; Waks, A. G.; Braso-Maristany, F.; Pardo, F.; Manning, D. K.; Abery, J. A.; Curaba, J.; Moon, L.; Gordon, O.; Galvan, P.; Wachirakantapong, P.; Castillo, O.; Nee, C. M.; Blasco, P.; Senevirathne, T. H.; Sirenko, V.; Martinez-Saez, O.; Aguirre, A.; Krop, I. E.; Li, Z.; Spellman, P.; Metzger Filho, O.; Polyak, K.; Michaels, P.; Puig-Butille, J. A.; Vivancos, A.; Matito, J.; Buckingham, W.; Perou, C. M.; Villagrasa-Gonzalez, P.; Prat, A.; Parker, J. S.; Pare, L.
Efficacy of spartalizumab across multiple cancer types in patients with PD1-high mRNA expressing tumors (SOLTI1904 ACROPOLI)

spartalizumab在表达PD1-high mRNA的肿瘤患者中跨多种癌症类型的疗效 (SOLTI1904 ACROPOLI)

ANNALS OF ONCOLOGY
IF65.4
2023-10-010
OA
Prat, A.; Pascual, T.; Juan, M.; Paz-Ares, L.; Felip, E.; Garralda, E.; Gonzalez-farre, B.; Fernandez, A. M. Arance; Martin-Liberal, J.; Lopez, A.; Peron, Y. Izarzugaza; Garcia-Corbacho, J.; Manich, C. Saura; Hierro, C.; Torres, E. Sanfeliu; Cejalvo, J. M.; Salvador, F.; Nin, R. Mesia; Cervantes, A.; Tabernero, J.
Gene expression profiling in tumors with and without tertiary lymphoid structures across cancer-types

跨癌症类型的具有和不具有三级淋巴样结构的肿瘤中的基因表达谱

ANNALS OF ONCOLOGY
IF65.4
2023-10-010
PRE
Segui Solis, E.; Pascual, T.; Sanfeliu Torres, E.; Gonzalez-Farre, B.; Braso-Maristany, F.; Gonzalez Farre, X.; Salvador, F.; Felip, E.; Garralda, E.; Paz-Ares, L.; J. Otero, M.; Mesia Nin, R.; Arance Fernandez, A. M.; Cervantes, A.; Martin-Liberal, J.; Gavila-Gregori, J.; Amillano Parraga, K.; E. Racca, F.; Tabernero, J.; Prat, A.
Tumor-infiltrating lymphocites and gene expression across multiple cancer-types: A translational analysis from the SOLTI-1904-ACROPOLI study

肿瘤浸润性淋巴细胞和多种癌症类型的基因表达: 来自SOLTI-1904-ACROPOLI研究的翻译分析

ANNALS OF ONCOLOGY
IF65.4
2023-10-010
PRE
Segui Solis, E.; Sanfeliu Torres, E.; Gonzalez-Farre, B.; Pascual, T.; Braso-Maristany, F.; Galvan, P.; Gonzalez Farre, X.; Salvador, F.; Felip, E.; Garralda, E.; Paz-Ares, L.; Juan, M.; Mesia Nin, R.; Arance Fernandez, A. M.; Cervantes, A.; Martin-Liberal, J.; Villacampa Javierre, G.; Tabernero, J.; Prat, A.
Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of- opportunity SOLTI TOT-HER3 pre-operative study
ANNALS OF ONCOLOGY
IF65.4
2023-08-0116
PRE
Oliveira, M.; Falato, C.; Cejalvo, J. M.; Vila, M. Margeli; Tolosa, P.; Salvador-Bo, F. J.; Cruz, J.; Arumi, M.; Luna, A. M.; Guerra, J. A.; Vidal, M.; Martinez-Saez, O.; Pare, L.; Gonzalez-Farre, B.; Sanfeliu, E.; Ciruelos, E.; Espinosa-Bravo, M.; Pernas, S.; Izarzugaza, Y.; Esker, S.; Fan, P. -D; Parul, P.; Santhanagopal, A.; Sellami, D.; Villacampa, G.; Ferrero-Cafiero, J. M.; Pascual, T.; Prat, A.
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer (vol 7, 1, 2021)
NPJ BREAST CANCER
IF7.6
2023-04-292
OAAI
Schettini, Francesco; Chic, Nuria; Braso-Maristany, Fara; Pare, Laia; Pascual, Tomas; Conte, Benedetta; Martinez-Saez, Olga; Adamo, Barbara; Vidal, Maria; Barnadas, Esther; Fernandez-Martinez, Aranzazu; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Cejalvo, Juan Miguel; Perrone, Giuseppe; Sabarese, Giovanna; Zalfa, Francesca; Peg, Vicente; Fasani, Roberta; Villagrasa, Patricia; Gavila, Joaquin; Barrios, Carlos H.; Lluch, Ana; Martin, Miguel; Locci, Mariavittoria; De Placido, Sabino; Prat, Aleix

研究方向

暂未获取到该数据
A
Aleix Prat
H 指数:92论文数:1,351被引数:3.6万
T
Tomás Pascual
H 指数:35论文数:449被引数:5,492
P
Patricia Galván
H 指数:37论文数:313被引数:6,528
M
Montserrat Muñoz-Mateu
H 指数:50论文数:620被引数:9,870
M
María Vidal
H 指数:43论文数:425被引数:1.1万
N
Núria Chic
H 指数:20论文数:149被引数:2,745
F
Fara Brasó‐Maristany
H 指数:28论文数:304被引数:3,776
B
Bárbara Adamo
H 指数:41论文数:293被引数:7,977
E
Esther Sanfeliu
H 指数:19论文数:131被引数:2,726
P
Patricia Villagrasa
H 指数:28论文数:207被引数:3,476